Literature DB >> 22886090

Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.

F Dusemund1, B Bucher, S Meyer, R Thomann, F Kühn, S Bassetti, M Sprenger, E Baechli, T Sigrist, M Schwietert, D Amin, P Hausfater, E Carre, P Schuetz, J Gaillat, K Regez, R Bossart, U Schild, B Müller, W C Albrich.   

Abstract

Procalcitonin (PCT)-guided antibiotic stewardship is a successful strategy to decrease antibiotic use. We assessed if clinical judgement affected compliance with a PCT-algorithm for antibiotic prescribing in a multicenter surveillance of patients with lower respiratory tract infections (LRTI). Initiation and duration of antibiotic therapy, adherence to a PCT algorithm and outcome were monitored in consecutive adults with LRTI who were enrolled in a prospective observational quality control. We correlated initial clinical judgment of the treating physician with algorithm compliance and assessed the influence of PCT on the final decision to initiate antibiotic therapy. PCT levels correlated with physicians' estimates of the likelihood of bacterial infection (p for trend <0.02). PCT influenced the post-test probability of antibiotic initiation with a greater effect in patients with non-pneumonia LRTI (e.g., for bronchitis: -23 % if PCT ≤ 0.25 μg/L and +31 % if PCT > 0.25 μg/L), in European centers (e.g., in France -22 % if PCT ≤ 0.25 μg/L and +13 % if PCT > 0.25 μg/L) and in centers, which had previous experience with the PCT-algorithm (-16 % if PCT ≤ 0.25 μg/L and +19 % if PCT > 0.25 μg/L). Algorithm non-compliance, i.e. antibiotic prescribing despite low PCT-levels, was independently predicted by the likelihood of a bacterial infection as judged by the treating physician. Compliance was significantly associated with identification of a bacterial etiology (p = 0.01). Compliance with PCT-guided antibiotic stewardship was affected by geographically and culturally-influenced subjective clinical judgment. Initiation of antibiotic therapy was altered by PCT levels. Differential compliance with antibiotic stewardship efforts contributes to geographical differences in antibiotic prescribing habits and potentially influences antibiotic resistance rates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886090     DOI: 10.1007/s10096-012-1713-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

1.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Authors:  Mirjam Christ-Crain; Daiana Jaccard-Stolz; Roland Bingisser; Mikael M Gencay; Peter R Huber; Michael Tamm; Beat Müller
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

2.  Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland.

Authors:  Massimo Filippini; Giuliano Masiero; Karine Moschetti
Journal:  Health Policy       Date:  2005-11-10       Impact factor: 2.980

Review 3.  Clinical practice. Acute bronchitis.

Authors:  Richard P Wenzel; Alpha A Fowler
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

Review 4.  Diagnostic tests for agents of community-acquired pneumonia.

Authors:  John G Bartlett
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

5.  Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

Authors:  R Gonzales; J F Steiner; M A Sande
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

6.  Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002.

Authors:  Roger G Finch; Joshua P Metlay; Peter G Davey; Lee J Baker
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

7.  Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia.

Authors:  Drahomir Aujesky; Julie B McCausland; Jeff Whittle; D Scott Obrosky; Donald M Yealy; Michael J Fine
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

8.  The impact of antimicrobial resistance on health and economic outcomes.

Authors:  Sara E Cosgrove; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

9.  Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Marcel Wolbers; Ursula Schild; Robert Thomann; Claudine Falconnier; Isabelle Widmer; Stefanie Neidert; Claudine A Blum; Ronald Schönenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Müller
Journal:  BMC Health Serv Res       Date:  2007-07-05       Impact factor: 2.655

10.  Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007.

Authors:  Elifsu Sabuncu; Julie David; Claire Bernède-Bauduin; Sophie Pépin; Michel Leroy; Pierre-Yves Boëlle; Laurence Watier; Didier Guillemot
Journal:  PLoS Med       Date:  2009-06-02       Impact factor: 11.069

View more
  7 in total

1.  [Severe infections : causes and management of sepsis].

Authors:  B Salzberger; F Hanses; G Birkenfeld; J Langgartner
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

Review 2.  Update on procalcitonin measurements.

Authors:  Michael Meisner
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

Review 3.  Procalcitonin-guided diagnosis and antibiotic stewardship revisited.

Authors:  Ramon Sager; Alexander Kutz; Beat Mueller; Philipp Schuetz
Journal:  BMC Med       Date:  2017-01-24       Impact factor: 8.775

4.  Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.

Authors:  A Soh; L Binder; M Clough; M Hernandez Hernandez; G Lefèvre; K Mostert; T B Nguyen; K-M Otte; O Portakal; M S Sandri; J L Yen; J Huang; A Beshiri
Journal:  Pract Lab Med       Date:  2018-11-09

5.  Point-of-care testing for community-acquired pneumonia.

Authors:  Michel Drancourt; Charlotte A Gaydos; James T Summersgill; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2013-08       Impact factor: 25.071

6.  Serum Procalcitonin Measurement and Viral Testing to Guide Antibiotic Use for Respiratory Infections in Hospitalized Adults: A Randomized Controlled Trial.

Authors:  Angela R Branche; Edward E Walsh; Roberto Vargas; Barbara Hulbert; Maria A Formica; Andrea Baran; Derick R Peterson; Ann R Falsey
Journal:  J Infect Dis       Date:  2015-04-24       Impact factor: 5.226

7.  Provider Decisions to Treat Respiratory Illnesses with Antibiotics: Insights from a Randomized Controlled Trial.

Authors:  Angela R Branche; Edward E Walsh; Nagesh Jadhav; Rachel Karmally; Andrea Baran; Derick R Peterson; Ann R Falsey
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.